Filing Details

Accession Number:
0001415889-21-001528
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-16 21:37:21
Reporting Period:
2021-03-12
Accepted Time:
2021-03-16 21:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901534 P Fred Lampropoulos 1600 West Merit Parkway
South Jordan UT 84095
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Disposition 2021-03-12 4,947 $59.60 967,916 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 95,863 Indirect By 401(k) Plan
Common Stock, No Par Value 90 Indirect By spouse as custodian for child
Common Stock, No Par Value 1,269 Indirect By spouse
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $17.27 2016-02-13 2022-02-13 5,000 5,000 Indirect
Common Stock Non-qualified stock options (right to buy) $16.05 2017-01-28 2023-01-28 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $16.05 2017-01-28 2023-01-28 6,000 6,000 Indirect
Common Stock Non-qualified stock options (right to buy) $28.20 2018-04-14 2024-04-14 200,000 200,000 Direct
Common Stock Non-qualified stock options (right to buy) $28.20 2018-04-14 2024-04-14 6,000 6,000 Indirect
Common Stock Non-qualified stock options (right to buy) $44.80 2019-03-02 2025-03-02 38,002 38,002 Direct
Common Stock Non-qualified stock options (right to buy) $44.80 2019-03-02 2025-03-02 4,000 4,000 Indirect
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 159,151 159,151 Direct
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 2,000 2,000 Indirect
Common Stock Non-qualified stock options (right to buy) $37.71 2021-02-26 2027-02-26 100,334 100,334 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-02-13 5,000 5,000 Indirect
2023-01-28 50,000 50,000 Direct
2023-01-28 6,000 6,000 Indirect
2024-04-14 200,000 200,000 Direct
2024-04-14 6,000 6,000 Indirect
2025-03-02 38,002 38,002 Direct
2025-03-02 4,000 4,000 Indirect
2026-03-01 159,151 159,151 Direct
2026-03-01 2,000 2,000 Indirect
2027-02-26 100,334 100,334 Direct
Footnotes
  1. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $59.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  2. Represents plan holdings as of 2/26/2021.
  3. Became exercisable in equal annual installments of 20% commencing 2/13/2016.
  4. Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
  5. Becomes exercisable in equal annual installments of 20% commencing 1/28/2017.
  6. Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.
  7. Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
  8. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
  9. Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
  10. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
  11. Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
  12. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
  13. Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.